We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Analyzer Goes Wireless

By LabMedica International staff writers
Posted on 13 Apr 2011
A point-of-care hand-held analyzer allows real time transmission of diagnostic test results generated directly from the patient bedside.

The handheld analyzer can potentially save precious time by allowing caregivers to perform critical tests at the bedside and then transmit test results immediately so they can be reviewed by physicians anywhere they have access to electronic records.

The device, called the i-STAT 1 Wireless, eliminates the back-and-forth movement from the bedside to a desktop transmission terminal somewhere in the department giving staff the ability to focus on the patient better. More...
For example, with the 10-minute i-STAT cardiac troponin test cartridge, emergency department staffs can test, transmit, and treat from the bedside. By sharing these test results via a hospital's existing wireless network, caregivers have rapid access to information that can help determine if a patient is having a heart attack.

The i-STAT 1 Wireless is the latest version of the device from Abbott Laboratories, (Abbott Park, IL, USA). Lightweight, portable, and easy to use, the i-STAT System features single-use disposable cartridges that perform a broad menu of the most commonly performed diagnostic tests, including cardiac markers, blood gases, chemistries and electrolytes, lactate, coagulation, and hematology. Abbott announced it has received clearance from the US Food and Drug Administration (FDA; Silver Springs, MD, USA), to begin marketing the i-STAT 1 Wireless.

Greg E. Arnsdorff, head of Abbott's point of care business, said, "By empowering nurses to stay at the bedside, the new i-STAT 1 Wireless supports a patient-focused approach to treatment, allowing for expedited decision making that helps minimize time to treatment." The i-STAT System is used in nearly 2,000 hospitals and in nearly 1,000 emergency departments in the US. Some 50,000 i-STAT analyzers are used worldwide and they process about 100 million test cartridges a year.

Related Links:
Abbott Laboratories
FDA


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Blood Glucose Test Strip
AutoSense Test
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.